| Absence of LPA1 Signaling Results in Defective Cortical Development G Estivill-Torrús, P Llebrez-Zayas, E Matas-Rico, L Santín, C Pedraza, ... Cerebral cortex 18 (4), 938-950, 2008 | 177 | 2008 |
| Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus E Matas-Rico, B García-Diaz, P Llebrez-Zayas, D López-Barroso, L Santín, ... Molecular and Cellular Neuroscience 39 (3), 342-355, 2008 | 156 | 2008 |
| Behavioral phenotype of maLPA1‐null mice: increased anxiety‐like behavior and spatial memory deficits LJ Santin, A Bilbao, C Pedraza, E Matas‐Rico, D Lopez‐Barroso, ... Genes, Brain and Behavior 8 (8), 772-784, 2009 | 105 | 2009 |
| Exploratory, anxiety and spatial memory impairments are dissociated in mice lacking the LPA1 receptor E Castilla-Ortega, J Sánchez-López, C Hoyo-Becerra, E Matas-Rico, ... Neurobiology of learning and memory 94 (1), 73-82, 2010 | 101 | 2010 |
| LPA Is a Chemorepellent for B16 Melanoma Cells: Action through the cAMP-Elevating LPA5 Receptor M Jongsma, E Matas-Rico, A Rzadkowski, K Jalink, WH Moolenaar PloS one 6 (12), e29260, 2011 | 99 | 2011 |
| Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling WJ Keune, J Hausmann, R Bolier, D Tolenaars, A Kremer, T Heidebrecht, ... Nature communications 7 (1), 11248, 2016 | 92 | 2016 |
| Glycerophosphodiesterase GDE2 promotes neuroblastoma differentiation through glypican release and is a marker of clinical outcome E Matas-Rico, M van Veen, D Leyton-Puig, J van den Berg, J Koster, ... Cancer cell 30 (4), 548-562, 2016 | 61 | 2016 |
| Autotaxin impedes anti-tumor immunity by suppressing chemotaxis and tumor infiltration of CD8+ T cells E Matas-Rico, E Frijlink, I van der Haar Àvila, A Menegakis, M van Zon, ... Cell reports 37 (7), 2021 | 54 | 2021 |
| Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells M Van Veen, E Matas-Rico, K van de Wetering, D Leyton-Puig, ... Elife 6, e23649, 2017 | 54 | 2017 |
| Loss of lysophosphatidic acid receptor LPA1 alters oligodendrocyte differentiation and myelination in the mouse cerebral cortex B García-Díaz, R Riquelme, I Varela-Nieto, AJ Jiménez, I de Diego, ... Brain Structure and Function 220, 3701-3720, 2015 | 43 | 2015 |
| GDE2-RECK controls ADAM10 α-secretase–mediated cleavage of amyloid precursor protein M Nakamura, Y Li, BR Choi, E Matas-Rico, J Troncoso, C Takahashi, ... Science translational medicine 13 (585), eabe6178, 2021 | 25 | 2021 |
| Neuronal differentiation through GPI-anchor cleavage E Matas-Rico, M van Veen, WH Moolenaar Cell cycle 16 (5), 388-389, 2017 | 18 | 2017 |
| Sequence-dependent trafficking and activity of GDE2, a GPI-specific phospholipase promoting neuronal differentiation F Salgado-Polo, M van Veen, B van den Broek, K Jalink, D Leyton-Puig, ... Journal of cell science 133 (3), jcs235044, 2020 | 14 | 2020 |
| Glycerophosphodiesterase GDE2/GDPD5 affects pancreas differentiation in zebrafish M van Veen, LA Mans, E Matas-Rico, J van Pelt, A Perrakis, ... The international journal of biochemistry & cell biology 94, 71-78, 2018 | 11 | 2018 |
| GABAergic deficits in absence of LPA1 receptor, associated anxiety-like and coping behaviors, and amelioration by interneuron precursor transplants into the … C Rosell-Valle, M Martínez-Losa, E Matas-Rico, E Castilla-Ortega, ... Brain Structure and Function 226, 1479-1495, 2021 | 8 | 2021 |
| New perspectives on the role of liquid biopsy in bladder cancer: applicability to precision medicine F Alberca-del Arco, D Prieto-Cuadra, R Santos-Perez de la Blanca, ... Cancers 16 (4), 803, 2024 | 3 | 2024 |
| GDE2/GDPD5 in neuroblastoma E Matas-Rico, M van Veen, WH Moolenaar Oncotarget 8 (4), 5672, 2016 | 3 | 2016 |
| Tumor immune escape by autotaxin: keeping eosinophils at bay E Matas-Rico, WH Moolenaar Trends in Cancer, 2024 | 2 | 2024 |
| A novel autotaxin inhibitor, IOA-289, modulates tumor, immune and stromal cell function and has monotherapy activity in fibrotic cancer models MA Deken, K Niewola-Staszkowska, E Matas-Rico, A Fraser, R Medhi, ... Journal for ImmunoTherapy of Cancer 9, A967-A967, 2021 | 2 | 2021 |
| Defective myelination in mice lacking the lysophosphatidic acid receptor LPA1: newcomer models for demyelinating diseases B García-Díaz, E Matas-Rico, R Riquelme, I Varela-Nieto, AJ Jimenez, ... Multiple Sclerosis 13, S258-S258, 2007 | 2 | 2007 |
